CV LinkedIn Certs Contact
MBA Pharmaceutical Management · IIHMR University

Animesh
Mishra

|

B.Pharm (Honours) graduate and MBA Pharmaceutical Management candidate at IIHMR University, Jaipur — currently interning as a Product Management Trainee at Micro Labs Ltd. across CNS and cardiology therapy areas. My edge: a laboratory-trained mind applied to commercial problems. I've operated an HPLC, analysed IQVIA market data, modelled M&A financials, and coded ICD-10-CM diagnoses. Most candidates bring one lens. I bring four.

Hire Me for PMT Preview 1-page Resume View My Work
Animesh Mishra
Interning · Open post-MBA
0
B.Pharm Score
0
Projects Delivered
0
ICD Codes Mastered
0
Credentials Earned
Pharma Strategy✦ Market Access✦ Health Economics✦ Clinical Data✦ Product Management✦ Generative AI✦ Pharma Strategy✦ Market Access✦ Health Economics✦ Clinical Data✦ Product Management✦ Generative AI✦
Who I Am

About Me

Personal Details
Animesh Mishra
MBA in Pharmaceutical Management
Home: Rewa, M.P. / Current: Jaipur, Rajasthan
IIHMR University
animesh.pm17@iihmr.in
+91 8989468728
Health EconomicsMarket AccessProduct ManagementMedical CodingQC AnalysisGMP ComplianceBrand StrategyGenerative AI
Languages
English (Professional) Hindi (Native)

I started in the lab at Unidrug Innovative Pharma Technologies, running HPLC, GC, and LC systems on live batches, applying GMP protocols, and learning firsthand that a failed QC process is a patient safety issue — not just a paperwork problem.

Then I went deeper into healthcare data — completing a certified ICD-10-CM medical coding programme with E-Cell, IIT Hyderabad, understanding how clinical documentation shapes revenue cycles and ultimately drives the commercial decisions pharma companies make.

Now at IIHMR University (MBA Pharmaceutical Management, Aug 2025 – 2027), I'm building frameworks for GTM Strategy, Market Access, KOL Engagement, Health Economics, and Lifecycle Management — targeting roles in PMT and pharma consulting at firms that demand both scientific rigour and business acumen.

"Molecule to Market — I understand the molecule and the market. Not as a metaphor. Literally. That intersection is where I operate."
Dual Lens
Lab-trained scientist + MBA strategist. I read clinical data and boardroom decks with equal fluency — rare at entry level.
Data-Driven
From HPLC batch records to IQVIA market analytics — decisions backed by numbers, not intuition alone.
AI-First
IBM-certified AI in Product Management. I don't just use AI tools — I build workflows and frameworks around them.
Published
Peer-reviewed research on ethosomal curcumin drug delivery — first-author, ResearchGate indexed, DOI-referenced.
Expertise

Skills & Competencies

🧬

Pharma & Clinical Sciences

Lab operations · Regulatory · Clinical data
ICD-10-CM Coding GMP Compliance CAPA Management HPLC / GC / LC Pharmacovigilance Drug Formulation Batch Release Quality Control Clinical Documentation Revenue Cycle Coding
200+ ICD-10-CM codes — certified by E-Cell, IIT Hyderabad
📈

Business Strategy & Market Access

Go-to-market · HEOR · Commercial strategy
Health Economics Market Access GTM Strategy Brand Management Lifecycle Management KOL Engagement RCPA Analysis IQVIA Analytics SWOT / PESTEL NPV / WACC Modelling Competitive Intelligence Pricing Strategy
NPV / WACC / EV-EBITDA modelling — applied to live pharma M&A and patent-cliff scenarios
🤖

AI, Digital & Product Management

GenAI · Product thinking · Digital health
Generative AI Prompt Engineering AI Product Management Product Roadmapping User Story Writing Agile / Scrum Power BI Microsoft 365 Firebase React / Vite Digital Health Apps Workflow Automation
IBM-certified in AI for Product Management · upGrad × Microsoft certified in Generative AI Foundations
🎯

Research, Communication & Leadership

Academic research · Presentation · Cross-functional
Scientific Writing Research Publication Data Analysis Stakeholder Management Cross-functional Collaboration Medical Communication Problem Solving Critical Thinking Presentation Design Team Leadership
First-author published research on Ethosomal Curcumin Drug Delivery — DOI: 10.13140/RG.2.2.36647.10405
Click any pharma term (dotted underline) for a quick definition.
Tools & Platforms I Work With
📊 Microsoft Excel 📑 PowerPoint 📝 Microsoft Word 📈 Power BI 🤖 ChatGPT / Claude 🔥 Firebase ⚛️ React / Vite 🧪 HPLC / GC Systems 📦 IQVIA Analytics 🗃️ ICD-10-CM Coding 🌐 LinkedIn 📁 Google Workspace 📊 Tableau 🎨 Canva
My Journey

Professional Experience

May 2026 — Present
Product Management Intern ● Ongoing
Micro Labs Ltd. — Jaipur
  • Gaining hands-on exposure to PMT workflows — observing how medical, marketing, and field force teams align around therapy area strategy in CNS and cardiology
  • Conducting market research and HCP insight analysis for Rasagiline and Apixaban to understand prescribing dynamics and competitive landscape
  • Learning to apply SWOT and PESTEL frameworks in real product strategy discussions alongside experienced brand managers
  • Building understanding of how promotional materials, detailing cycles, and HCP targeting translate brand objectives into field execution
Jan — Mar 2024
Medical Coding Analyst (Certified)
E-Cell, IIT Hyderabad
  • Achieved operational proficiency across 200+ ICD-10-CM diagnostic codes, translating clinical language into structured healthcare data
  • Deepened understanding of international drug nomenclature and therapeutic classifications relevant to pharmacovigilance
  • Gained structured exposure to how coding accuracy shapes hospital revenue cycles and insurance reimbursement decisions
Jul 1 — 15, 2023
QC Analyst Intern
Unidrug Innovative Pharma Technologies Ltd. — Indore
  • Operated HPLC, GC, and LC instruments on live pharmaceutical batches applying GMP protocols that supported regulatory release decisions
  • Independently processed 20+ batch samples per cycle, contributing to zero-delay batch releases during peak production period
  • Collaborated with manufacturing to redesign desiccation protocols, improving batch consistency and CAPA compliance
Jun 1 — 22, 2023
Pharma Industry Trainee
SIRTSP / CARE, The SAGE Group — Bhopal
  • Completed 4-week Hands-on Training cum Workshop: Exposure to Formulation & Evaluation of Pharmaceutical Products as per Industry
  • Conducted live plant visits to Indian Capsule Ltd. and an Ayurvedic nutraceutical facility, gaining end-to-end supply chain visibility
  • Bridged academic pharmacology with operational realities of pharmaceutical commercialisation and market-entry constraints
How I Work

From Insight to Execution

01

Discovery

Read clinical data, secondary research, IQVIA exports, and HCP voice. The right question shapes the right strategy.

e.g. RCPA + IQVIA scan before the Semaglutide patent-cliff brief
02

Insight

Synthesise data into a one-line "so what?" — the insight that survives a brand review and a CFO challenge alike.

e.g. The biosimilar entry curve hides a 12-month premium-defence window
03

Strategy

Frame options against SWOT/PESTEL, model NPV/WACC, and pick a defensible play with clear KPIs.

e.g. Lifecycle plays + KOL re-engagement to defend brand share
04

Execution

Translate strategy into briefs, dashboards, and field-force messaging — with measurable feedback loops.

e.g. PMT detailing decks, IQVIA dashboards, AI workflow prototypes
Academic Background

My Education

Postgraduate
MBA Pharmaceutical Management
IIHMR University, Jaipur
Aug 2025 – 2027
Currently Pursuing
Undergraduate
B. Pharm (Honours)
RGPV / NRI Institute of Pharmacy, Bhopal
Jun 2020 – Jul 2024
78%
Lead Researcher — Herbal Hand Sanitizer formulation study; NIPER JEE Qualified (2024)
Class XII — CBSE
Higher Secondary Certificate
Sacred Heart Convent School
2019
Class X — CBSE
Secondary School Certificate
Sacred Heart Convent School
2017
My Work

Featured Projects

Projects

6 strategic case studies

PharmaIntel

13-language platform

Data Depth

20-table schema

📈
Semaglutide Patent Cliff case-study cover

Semaglutide Patent Cliff Analysis

Executive-level GLP-1 patent expiry impact analysis using IQVIA Market Reflection data. Presented as academic brief and LinkedIn carousel.

$20B+ marketPatent StrategyGLP-1IQVIA
View Details
📱
PharmaIntel India case-study cover

PharmaIntel India App

Multilingual Indian pharma intelligence platform — 13 regional languages, offline-first, 20-table SQLite schema on React/Firebase/Vite.

13 languages20-table schemaReactFirebasePWA
View Details
🧠
AMR-Genius Intelligence Hub case-study cover

AMR-Genius Intelligence Hub

AI-powered AMR surveillance platform with business model canvas, monetisation plan, and data architecture — Research Methods, IIHMR.

SaaS BMCAI/MLAMR
View Details
🔬
Ethosomal Curcumin research paper cover

Ethosomal Curcumin — Research Paper

Peer-reviewed narrative review on ethosomal vs. liposomal curcumin delivery systems. Published with DOI on ResearchGate.

DOI · First-authorScientific WritingDrug Delivery
View Details
🤖
PharmAdhere-AI case-study cover

PharmAdhere-AI

Predictive AI framework for pharmaceutical patient adherence modelling, integrating ML with patient behaviour analytics.

ML frameworkPredictive AIAdherence
View Details
🏢
Featured Sun Pharma × Organon M&A case-study cover

Sun Pharma × Organon — M&A Deep Dive

15-section executive-grade analysis of India's largest-ever pharma acquisition: $11.75B deal mechanics, financial leverage modelling, 4 strategic pillars, governance crisis, and capital market reactions.

$11.75B deal15 sectionsM&A Strategy
View Details
📄

Curriculum Vitae

Animesh Mishra · MBA Pharmaceutical Management
Open in new tab Download CV
📈

Semaglutide Patent Cliff Analysis

Strategic Intelligence · IQVIA Market Reflection · 2025
Semaglutide Patent Cliff cover

An executive-level analysis of the GLP-1 patent expiry landscape for semaglutide, examining the commercial implications of Novo Nordisk's Ozempic and Wegovy patents approaching expiration and the anticipated biosimilar entry wave.

Mapped competitive biosimilar entry timelines, estimated market-share erosion scenarios using IQVIA Market Reflection data, and proposed lifecycle management strategies. Quantified the impact on the $20B+ global GLP-1 market and identified adjacent therapeutic opportunities.

Delivered as an academic brief and a LinkedIn carousel, demonstrating applied pharmaceutical business intelligence, lifecycle management, and executive communication competencies.

Patent StrategyGLP-1IQVIALifecycle ManagementBiosimilars
Research Foundation
AstraZeneca Nexium Case (DocMode, 2015) — Purple Pill lifecycle management: brand repositioning via premium pricing & patient education to protect revenue post-patent expiry. Validated LCM strategies applied in this analysis.
Novartis Gilenya Launch (DocMode, 2015) — Disease-education-led launch at $48,000/year (20× over generic), targeting neurologists with unbranded awareness campaigns. Informs premium biosimilar defence frameworks used in this study.
Case Study PDF View on LinkedIn
📱

PharmaIntel India App

Full-Stack PWA · React · Firebase · Vite · SQLite
PharmaIntel India cover

A comprehensive multilingual pharmaceutical intelligence platform for Indian healthcare professionals. Supports 13 regional languages and is built offline-first, ensuring accessibility in low-connectivity areas across Tier 2 and 3 cities.

Architecture: A 20-table SQLite schema organises drug data, therapeutic categories, and regional formulary information. Firebase handles authentication and real-time sync; Vite/React powers the progressive web app frontend.

Key features include drug-drug interaction checks, DPCO pricing compliance, Indian brand-to-generic mapping, and offline access to the Indian National Formulary — directly relevant to field force and medical affairs applications.

ReactFirebasePWASQLiteMultilingual
Research Foundation
Smilax Labs Marketing Study (IOSR-JBM, 2013) — Field force effectiveness and detailing strategies in Indian pharma markets reveal the critical gap in real-time drug intelligence tools accessible to HCPs — the core problem PharmaIntel India solves.
Novo Nordisk India Diabetes Awareness (DocMode, 2015) — Digital patient education through vernacular content in 9 languages demonstrated the viability of multilingual health communication in India, directly informing the app's 13-language architecture.
Case Study PDF View on LinkedIn
🧠

AMR-Genius Intelligence Hub

AI Platform Concept · Research Methods · IIHMR 2025
AMR-Genius cover

An AI-powered antimicrobial resistance (AMR) surveillance platform concept addressing the growing global AMR crisis — projected to cause 10 million deaths annually by 2050 — by aggregating hospital antibiogram data and predicting resistance patterns in real time.

Deliverables included a full Business Model Canvas, three-tier monetisation plan (institutional, government, research), graph-database-powered data architecture, and market sizing analysis for the Indian AMR diagnostics segment.

Demonstrates the integration of AI/ML methodology with health economics frameworks — direct application of MBA curriculum to a £1B+ public health opportunity in India's post-AMR policy landscape.

AI/MLAMRSaaSHealth EconomicsEpidemiology
Research Foundation
IIM Ahmedabad — Optimization-Based DSS for Pharma (2016) — Demonstrates how multi-objective optimisation and scenario modelling can guide strategic decisions in pharmaceutical companies. AMR-Genius applies this DSS framework to antibiogram surveillance and resistance prediction.
Vertex Pharmaceuticals Incivek Launch (DocMode, 2015) — Risk-share contracting and outcomes-based pricing in speciality pharma validated the health-economics monetisation model used in AMR-Genius's institutional tier pricing strategy.
Case Study PDF View on LinkedIn
🔬

Ethosomal Curcumin — Narrative Review

Peer-Reviewed Publication · Drug Delivery · DOI: 10.13140/RG.2.2.36647.10405
Ethosomal Curcumin cover

A publication-ready narrative review comparing ethosomal and liposomal drug delivery systems for curcumin — a compound with well-established anti-inflammatory and anti-cancer properties but notoriously poor oral bioavailability (~1%).

Critically examined 40+ peer-reviewed publications, evaluating encapsulation efficiency, transdermal permeation rates, vesicular stability profiles, and clinical translation potential of both systems across oncology, dermatology, and nutraceutical applications.

The manuscript progressed through peer review and citation auditing, achieving a published DOI on ResearchGate — demonstrating scientific writing competence at publication-ready standard, a key differentiator in medical affairs, regulatory, and PharmD-adjacent roles.

Scientific WritingDrug DeliveryNanotechnologyCurcuminPublished
View on ResearchGate (DOI) Case Study PDF
🤖

PharmAdhere-AI

AI Conceptual Framework · Patient Adherence · 2025
PharmAdhere-AI cover

A predictive AI framework for pharmaceutical patient adherence modelling — addressing one of the industry's most persistent and costly challenges, estimated to cost the global pharma sector $500B+ annually in lost revenue and suboptimal treatment outcomes.

The framework integrates: a behavioural prediction model trained on anonymised adherence patterns, a real-time risk stratification engine, and a personalised intervention recommendation system for clinical teams — built on federated learning principles to preserve data privacy.

Commercial potential mapped across pharma brand teams (lifecycle management), digital health platforms, and hospital pharmacy systems. Proposed data partnership model with CRM-integrated reminder ecosystems and HCP dashboards.

Predictive AIPatient AdherenceMLDigital HealthPharma Tech
Research Foundation
TBM Consulting — Pharma Operational Excellence (2015) — A pharma manufacturer reduced operating costs by 33% through structured performance management systems. PharmAdhere-AI applies the same execution-layer discipline to patient adherence KPIs, bridging clinical intent with measurable outcomes.
IIM Ahmedabad — Strategic DSS for Pharma (2016) — Multi-scenario optimisation under real-world constraints directly informs PharmAdhere-AI's risk stratification engine, which predicts adherence dropout across patient cohorts using federated learning.
Cornerstone4Care — Novo Nordisk (DocMode, 2015) — Integrated digital adherence platform for insulin patients demonstrated measurable compliance improvement at scale, providing precedent for the CRM-integrated reminder ecosystem in PharmAdhere-AI.
Case Study PDF View on LinkedIn
🏢

Sun Pharma × Organon — Comprehensive M&A Analysis

Strategic & Financial Analysis · Cross-Border Pharma M&A · April 2026
Sun Pharma × Organon cover
Challenge

Evaluating the strategic fit of India's largest $11.75B pharma acquisition amid a governance crisis at the target firm.

Result

Proved 27% PAT accretion and identified immediate post-close deleveraging path to 1.0x by FY30.

A comprehensive analysis of Sun Pharmaceutical Industries' acquisition of Organon & Co. Analysed the $14.00/share offer — a 103% premium yet a conservative 6.2x EV/EBITDA takeout multiple.

Strategic pillars: (1) Top-3 Women's Health position; (2) Instant entry as 7th-largest biosimilar manufacturer; (3) Cash engine of 15 brands individually >$100M; (4) Geographic de-risking via $800M China platform.

M&A StrategyFinance ModellingEV/EBITDAGovernanceCapital Markets
Research Foundation
TBM Consulting — Pharma Strategy Execution (2015) — Documents how a pharma manufacturer achieved 33% cost reduction through rigorous management systems. Post-acquisition integration analysis in this M&A study benchmarks Sun Pharma's operational synergy targets against this execution framework.
Smilax Labs — Pharma Marketing Strategies (IOSR-JBM, 2013) — Segmentation analysis of Indian pharma field force and brand positioning frameworks inform the commercial synergy assessment for Organon's Women's Health & biosimilar portfolio post-acquisition.
Case Study PDF View Full Case Study
 Patent Strategy

GLP-1 Patent Cliff: Semaglutide & the Biosimilar Wave

IQVIA Market Reflection · 2025
$20B+ Market 2026 Patent Expiry 8+ Biosimilar Entrants IQVIA Data

An executive-level analysis of the GLP-1 patent expiry landscape, examining the commercial implications of Novo Nordisk's Ozempic and Wegovy patents approaching expiration and the anticipated biosimilar wave.

The analysis mapped competitive biosimilar entry timelines across manufacturers in India, Europe, and the US — estimating market-share erosion scenarios using IQVIA Market Reflection data. Lifecycle management strategies for Novo Nordisk were proposed alongside adjacent therapeutic expansion opportunities in obesity and NASH.

Key Insights

  • Patent cliff analysis methodology — mapping expiry dates across geographic markets
  • Biosimilar regulatory pathways and their commercial timing implications
  • IQVIA Market Reflection interpretation for real-world brand performance
  • Lifecycle management strategies — new formulations, indications, patient support programmes
  • Market-share erosion modeling with quantified scenario outcomes
View on LinkedIn
 M&A Strategy

Sun Pharma × Organon: India's $11.75B Deal Decoded

Strategic & Financial Analysis · April 2026
Corporate M&A
$11.75B Deal 103% Premium 6.2x EV/EBITDA 15 Sections

A forensic 15-section breakdown of India's largest pharma acquisition — including deal mechanics ($14.00/share offer, 103% premium over unaffected share price), EV/EBITDA valuation, and strategic rationale across four pillars: Women's Health leadership, biosimilar scale, cash-generative brand portfolio, and China platform.

Analysed the governance crisis at Organon and its impact on deal pricing. Modelled post-close PAT accretion (27%) and deleveraging timeline to 1.0x Net Debt/EBITDA by FY30. Capital market reaction was assessed across NSE listing and global advisor mandates.

Key Insights

  • EV/EBITDA deal valuation mechanics in cross-border pharma M&A
  • Strategic portfolio synergy analysis — Women's Health, biosimilars, China platform
  • PAT accretion and deleveraging modeling post-acquisition
  • Governance crisis impact on deal pricing and premium justification
  • Capital market reactions and NSE performance analysis
View on LinkedIn
 Digital Health

AI in Pharma PMT: Reshaping Brand Planning & HCP Targeting

Opinion · MBA Research · IIHMR 2026
AI in Healthcare
GenAI Impact HCP Targeting Brand Planning GTM Strategy

An analytical piece examining how Generative AI is transforming go-to-market strategy, prescriber segmentation, and market access decisions in Indian pharma — with specific focus on the PMT function.

Key themes: AI-driven RCPA analysis replacing manual field data, LLM-powered KVA (key visual aid) personalisation by HCP segment, real-time competitor intelligence dashboards, and predictive HCP targeting models. Also covers ethical and regulatory boundaries of AI in pharma promotion.

Key Insights

  • GenAI applications in brand planning — automated content, personalised detailing
  • AI-enhanced RCPA analysis for real-time competitor prescription tracking
  • Predictive HCP targeting using prescribing behaviour models
  • Ethical and regulatory considerations for AI in pharma promotion
  • Skills PMT professionals need for the AI-augmented pharma environment
View on LinkedIn
🎓

Product Management: An Introduction

IBM / Coursera Professional Certificate · May 2026

What I Learned

  • Product lifecycle management from concept to market launch
  • Writing user stories, acceptance criteria, and product roadmaps
  • Agile and Scrum frameworks applied to pharma product development
  • AI integration in product management — automating discovery and prioritisation
  • Market requirements documentation and competitive analysis frameworks
  • Go-to-market strategy design and launch readiness assessment
IBM AI Product Manager Certificate
Open certificate
🤖

Generative AI Foundations Certificate

Microsoft × upGrad · UID: Br3hxZNKPVECfd81

What I Learned

  • Fundamentals of Large Language Models (LLMs) and transformer architecture
  • Prompt engineering techniques — few-shot, chain-of-thought, role-based prompting
  • Microsoft Copilot and Azure OpenAI service integration workflows
  • Responsible AI principles — bias, hallucination, and ethical boundaries
  • Building AI-augmented workflows for business analytics and content generation
  • Applied GenAI use cases in pharma: medical writing, market research, brand strategy
Generative AI Foundations Certificate — upGrad × Microsoft
Open certificate
🏥

Medical Coding Specialist — ICD-10-CM

E-Cell, IIT Hyderabad · Certificate ID: SDCERTI1031

What I Learned

  • 200+ ICD-10-CM alphanumeric diagnostic codes across major therapeutic areas
  • Clinical documentation standards and their role in revenue cycle management
  • Translating physician notes to standardised codes for insurance claims processing
  • International drug nomenclature and therapeutic area classification
  • Pharmacovigilance linkages — how coding accuracy affects drug safety reporting
  • Hospital billing systems and their commercial impact on pharma market access
Medical Coding Internship Certificate — Skill Dunia / ODCET Technologies
View Certificate Image View Completion PDF
🌐

Global Health Management Research Award

Pradanya 2026 — IIHMR University · February 2026

What I Learned

  • Structuring research papers for health management conferences and peer review
  • Strategic analysis frameworks applied to real-world global health challenges
  • Presenting complex pharmaceutical data to academic and industry audiences
  • GHMRC methodology — evidence-based health policy recommendations
  • Cross-disciplinary thinking: connecting health economics with operational strategy
Open certificate
🧪

Pharma Industry Training Workshop

SIRTSP / CARE, The SAGE Group — Bhopal · June 2023

What I Learned

  • Formulation and evaluation of pharmaceutical products per industry standards
  • Live plant visits to Indian Capsule Ltd. — end-to-end supply chain visibility
  • Ayurvedic nutraceutical manufacturing processes and quality frameworks
  • Pharmaceutical commercialisation and market-entry constraints
  • Bridging academic pharmacology with operational manufacturing realities
Open certificate
🏭

QC & Production Department Training

Unidrug Innovative Pharma Technologies Ltd. — Indore · July 2023

What I Learned

  • Hands-on operation of HPLC, GC, and LC instruments on live pharmaceutical batches
  • GMP protocol application — how regulatory compliance shapes every production decision
  • Batch release process — 20+ samples per cycle, zero-delay batch completion
  • CAPA implementation — redesigning desiccation protocols for batch consistency
  • Quality control as patient safety — connecting lab failures to real-world risk
Open certificate
🏆

AI Product Manager Specialisation

IBM — Coursera · 2026

What I Learned

  • Integrating AI/ML capabilities into product strategy and roadmapping
  • Defining AI-powered feature sets with measurable business outcomes
  • Evaluating AI model performance metrics relevant to product decisions
  • Building cross-functional workflows around AI-driven product development
  • Applied AI ethics — responsible AI frameworks for product managers
IBM AI Product Manager Certificate
Open certificate
🥇

NIPER JEE — Nationally Qualified

National Institute of Pharmaceutical Education & Research · 2024

Cleared the NIPER Joint Entrance Examination — India's most competitive postgraduate entrance for pharmaceutical sciences, administered by the National Institutes of Pharmaceutical Education and Research under the Ministry of Chemicals & Fertilizers.

Verification note: listed as a self-reported national qualification; official scorecard can be shared during screening if required.

Significance

  • One of the most competitive pharma science exams in India — tests pharmacology, chemistry, pharmaceutical sciences, and analytical reasoning
  • Demonstrates academic mastery of pharmaceutical sciences at a nationally competitive level
  • Validates deep scientific foundation prior to pursuing MBA Pharmaceutical Management
  • NIPER institutes are India's premier postgraduate pharma research institutions
📊

Advanced Excel Workshop

IIHMR Analytica Club, IIHMR University · March 2026

What I Learned

  • Advanced pivot tables and dynamic dashboards for market data analysis
  • Financial modelling — NPV, IRR, WACC calculations applied to pharma investments
  • Data visualisation techniques for presenting market access and HEOR data
  • VLOOKUP, INDEX-MATCH, and array formulas for large pharmaceutical datasets
  • Power Query for cleaning and transforming raw IQVIA / sales data
Open certificate
📚

 Pharma Glossary

Pharma Intelligence

Featured Insights

Pharma Market Analytics Patent Strategy

GLP-1 Patent Cliff: Semaglutide & the Biosimilar Wave

Executive analysis of Novo Nordisk's Ozempic/Wegovy patent expiry landscape, biosimilar entry timelines, and lifecycle management strategy in the $20B+ global GLP-1 market.

IQVIA Market Reflection · 2025
Read Analysis
Pharma M&A Strategy M&A Strategy

Sun Pharma × Organon: India's $11.75B Deal Decoded

Forensic 15-section breakdown of India's largest pharma acquisition — EV/EBITDA mechanics, Women's Health & biosimilar portfolios, governance crisis, and capital market reaction.

Strategic & Financial Analysis · April 2026
Read Analysis
AI in Pharma Digital Health

AI in Pharma PMT: Reshaping Brand Planning & HCP Targeting

How generative AI is transforming go-to-market strategy, prescriber segmentation, and market access decisions in Indian pharma — and what next-gen PMT professionals must prepare for.

Opinion · MBA Research · IIHMR 2026
Read Analysis
 View All Posts on LinkedIn
Credentials

Certifications & Achievements

🎓
Featured Completed
Product Management: An Introduction
IBM / Coursera · Professional Certificate
Issued: May 2026
View Details
🤖
Featured Completed
Generative AI Foundations Certificate
Microsoft × upGrad
UID: Br3hxZNKPVECfd81
View Details
🏥
Completed
Medical Coding Internship (ICD-10-CM)
E-Cell, IIT Hyderabad
ID: SDCERTI1031 · 200+ Codes Mastered
View Details
🌐
Awarded
Global Health Management Research Award
Pradanya 2026 · IIHMR University
February 2026 · Strategic Analysis
View Details
🧪
Completed
Pharma Industry Training Workshop
SIRTSP / CARE, The SAGE Group — Bhopal
June 1–22, 2023 · Formulation & Evaluation
View Details
🏭
Completed
QC & Production Department Training
Unidrug Innovative Pharma Technologies Ltd. — Indore
July 1–15, 2023
View Details
🏆
Certified
AI Product Manager Specialisation
IBM — Coursera
2026 · AI-Driven Product Strategy
View Details
🥇
Qualified
NIPER JEE — Nationally Qualified
National Institute of Pharmaceutical Education and Research
2024 · India's Premier Pharma Entrance
View Details
📊
Completed
Advanced Excel Workshop
IIHMR Analytica Club, IIHMR University
March 2026 · Pivot tables, dashboards & financial modelling
View Details
No certificates match your search.
Get in Touch

Let's Connect

Fresher  ·  Open to Full-time Roles · Post-MBA

B.Pharm (Hons.) + MBA Pharmaceutical Management fresher seeking entry-level roles in Product Management Trainee, Pharma Consulting, and Business Analyst. Lab-trained, clinically aware, and strategy-ready. I reply within 24 hours.

LinkedIn animesh-mishra-69a382378
Email animesh.pm17@iihmr.in
Phone +91 8989468728
WhatsApp Chat on WhatsApp
Location Jaipur, Rajasthan (Home: Rewa, M.P.)
Quick start: